Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
On November 9th, FoundationOne Liquid CDx, a sequencing-based assay of cell-free tumor DNA, from Foundation Medicine received the FDA approval for use as a companion diagnostic for patients with metastatic …
Read More